Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03103542
What this trial is testing

Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies

Who this might be right for
Hemophilia A
Swedish Orphan Biovitrum 16
Not applicableLooking for participantsNCT05916469
What this trial is testing

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Who this might be right for
Heavy Menstrual BleedingBleeding DisorderVon Willebrand Diseases
Oregon Health and Science University 300
Large-scale testing (Phase 3)Study completedNCT03528551
What this trial is testing

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 160
Not applicableStudy completedNCT00701545
What this trial is testing

A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)

Who this might be right for
Von Willebrand Disease
CSL Behring 21
Large-scale testing (Phase 3)Study completedNCT00606060
What this trial is testing

BAY14-2222 Continuous Infusion in Surgeries

Who this might be right for
Hemophilia
Bayer 15
Not applicableEnrolling By InvitationNCT07163260
What this trial is testing

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

Who this might be right for
Haemophilia
Novo Nordisk A/S 244
Not applicableUnknownNCT02324517
What this trial is testing

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders

Who this might be right for
Severe Hemophilia
Sheba Medical Center 300
Not applicableUnknownNCT01403740
What this trial is testing

Turkish Acquired Haemophilia Registry

Who this might be right for
Acquired Haemophilia
Turkish Society of Hematology 250
Not applicableUnknownNCT03946384
What this trial is testing

Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype

Who this might be right for
Hemophilia B
Centre Hospitalier Universitaire Dijon 12
Testing effectiveness (Phase 2)Ended earlyNCT04046848
What this trial is testing

Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Octapharma 36
Post-approval studies (Phase 4)Active Not RecruitingNCT05181618
What this trial is testing

Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Who this might be right for
Severe Hemophilia AModerate Hemophilia A
Hoffmann-La Roche 136
Not applicableStudy completedNCT05450640
What this trial is testing

Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in France

Who this might be right for
Hemophilia A
Hospices Civils de Lyon 176
Early research (Phase 1)Study completedNCT02213250
What this trial is testing

An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 12
Not applicableUnknownNCT03896997
What this trial is testing

Update in VWD Laboratory Diagnosis

Who this might be right for
VWD - Von Willebrand's Disease
Assiut University 100
Not applicableNot Yet RecruitingNCT07736976
What this trial is testing

Comparison of 30-Second Sit-to-Stand Test Performance Between Individuals With Hemophilia and Healthy Peers

Who this might be right for
Hemophilia A and B
Bahçeşehir University 58
Large-scale testing (Phase 3)Study completedNCT02210091
What this trial is testing

BAX 855 Pediatric Study

Who this might be right for
Hemophilia A
Baxalta now part of Shire 75
Large-scale testing (Phase 3)Study completedNCT02250482
What this trial is testing

An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.

Who this might be right for
Haemophilia A
Bio Products Laboratory
Large-scale testing (Phase 3)Study completedNCT02234310
What this trial is testing

Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B

Who this might be right for
Hemophilia B
Bioverativ, a Sanofi company 33
Large-scale testing (Phase 3)Active Not RecruitingNCT05203679
What this trial is testing

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

Who this might be right for
Hemophilia B
Shanghai Xinzhi BioMed Co., Ltd. 32
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Next Page